Twitter Facebook-f Youtube Instagram Linkedin
NETs Info
Donate
Close Menu
  • Who We Are
    • About Us
    • Our People
    • Our Board
    • Our Ambassadors
    • Consumer Advisory Group
    • Research Advisory Panel
    • Governance & Policy
  • Neuroendocrine Cancers
    • What are Neuroendocrine Cancers?
    • Patient Resources
    • Pheos and Paras
    • NET Library
  • I Am a Patient
    • Patient Support
    • Patient Resources
    • NET Nurse
    • Patient Stories
    • Australian NET Specialists
    • Current Clinical Trials
  • I am a HCP
    • Professional Learning
    • HCP – Patient Referral to NET Nurse
    • Current Clinical Trials
    • NET Library
    • HCP Newsletter & Signup
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
  • Get Involved
    • NET National Action Plan
    • Share your story
    • Donate
    • Fundraise
    • In Memoriam
    • Corporate Partners
    • Bequests
    • Workplace Giving
    • Volunteer
  • What’s On
    • News
    • Newsletter & Signup
    • INCA Newsletter archive
    • Events
  • Shop
  • Contact Us
Donate
  • Who We Are
    • About Us
    • Our People
    • Our Board
    • Our Ambassadors
    • Consumer Advisory Group
    • Research Advisory Panel
    • Governance & Policy
  • Neuroendocrine Cancers
    • What are Neuroendocrine Cancers?
    • Patient Resources
    • Pheos and Paras
    • NET Library
  • I Am a Patient
    • Patient Support
    • Patient Resources
    • NET Nurse
    • Patient Stories
    • Australian NET Specialists
    • Current Clinical Trials
  • I am a HCP
    • Professional Learning
    • HCP – Patient Referral to NET Nurse
    • Current Clinical Trials
    • NET Library
    • HCP Newsletter & Signup
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
  • Get Involved
    • NET National Action Plan
    • Share your story
    • Donate
    • Fundraise
    • In Memoriam
    • Corporate Partners
    • Bequests
    • Workplace Giving
    • Volunteer
  • What’s On
    • News
    • Newsletter & Signup
    • INCA Newsletter archive
    • Events
  • Shop
  • Contact Us

Home » Awareness » Introducing Australian Rare Cancer Portal

Introducing Australian Rare Cancer Portal

  • September 1, 2021

Building an online network of rare cancers clinicians and researchers to improve outcomes for patients – introducing the COSA-endorsed Australian Rare Cancer Portal

Australians diagnosed with rare or less common cancers and their doctors face extra challenges compared to those with more common cancers. These challenges include longer diagnosis times and difficulty accessing cancer specialists, molecular testing or specific treatments, as well as difficulties identifying information and support networks. To address this, the Australian Rare Cancer Portal (ARC Portal) has been established as an online platform to all Australian clinicians who are managing a patient with a rare cancers. Clinicians can refer patients to the ARC Portal to obtain streamlined access to rare cancer management guidelines; advice from a panel of Australian and International rare cancer specialists; guidance on molecular testing or interpretation of results; and help identifying clinical trials. Patients referred through the portal also consent toward use of their clinical data, and optionally biospecimens, for research. By providing a Nationwide approach to rare cancer patient and sample accrual, the ARC Portal aims to more rapidly collect clinically annotated rare cancer biospecimens that Australian researchers can access for ethically approved projects. This important initiative has recently been endorsed by COSA.

The Australian Rare Cancer Portal is led by Professors Clare Scott and David Goldstein funded by the Australian Cancer Genomics Medicine Centre (now known as Omico) and is managed by BioGrid Australia. 

Click here to find out more.

Share this post

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Subscribe to our eNews

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Recent posts

NeuroEndocrine Cancer Australia & Macquarie University study on important online resources for NET patients.

May 2, 2022

University of South Australia -Volunteers needed nationally.

April 27, 2022

Expression-of-Interest for consumer participation on Grant Review Committees for the 2022 Priority-driven Collaborative Cancer Research Scheme

April 27, 2022

When The Phone Rings

March 28, 2022
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousMedicines Australia, Room with a Patient View
NextPeter MacCallum 25th Anniversary of PRRT with Professor Rod HicksNext

Related Posts

NeuroEndocrine Cancer Australia & Macquarie University study on important online resources for NET patients.

NECA and Macquarie University are conducting a study to find out what people affected by neuroendocrine cancer identify as important when accessing online resources provided

University of South Australia -Volunteers needed nationally.

Are you undergoing, about to undergo, or recently completed treatment?  About the study Researchers at The University of South Australia are investigating the effects of

Expression-of-Interest for consumer participation on Grant Review Committees for the 2022 Priority-driven Collaborative Cancer Research Scheme

Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme (PdCCRS) is an innovative, competitive, annual cancer research projects grant funding scheme. The PdCCRS is conducted by Cancer

When The Phone Rings

A series of tests led to an unexpected cancer diagnosis and a summer reflecting on life, luck and the diligence of two doctors. Karen Middleton

View All

Make a difference

How much do you wish to donate?
$50
$100
$250
$500
$1000
Other
NeuroEndocrine Cancer Australia logo white
Twitter Facebook-f Youtube Instagram Linkedin

All donations are tax deductible.
Registered Charity CFN 202607

Who We Are

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • Research Advisory Panel
  • Governance & Policies
Menu
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • Research Advisory Panel
  • Governance & Policies

Neuroendocrine Cancers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
Menu
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

For Patients

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
Menu
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
Menu
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise

© 2020 NeuroEndocrine Cancer Australia

  • Website by Five Creative